Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 77 | 130 | 111 | 81 | 36 |
| Gross Profit | 77 | 130 | 111 | 81 | 36 |
| Operating Expenses | 2,829 | 8,562 | 7,759 | 8,455 | 7,821 |
| Operating Income | -2,752 | -8,432 | -7,648 | -8,374 | -7,785 |
| Interest Expense | 1,640 | 1,468 | 932 | 468 | 222 |
| Other Income | -6,881 | -4,748 | -3,938 | -602 | -630 |
| Pre-tax Income | -11,273 | -14,648 | -12,518 | -9,445 | -8,636 |
| Net Income Continuous | -11,273 | -14,648 | -12,518 | -9,445 | -8,636 |
| Net Income | $-11,273 | $-14,648 | $-12,518 | $-9,445 | $-8,636 |
| EPS Basic Total Ops | -28.56 | -2,200.00 | -5,466.67 | -5,800.00 | -7,000.00 |
| EPS Basic Continuous Ops | -28.56 | -2,191.78 | -5,468.68 | -5,806.38 | -7,011.42 |
| EPS Diluted Total Ops | -28.56 | -2,200.00 | -5,466.67 | -5,800.00 | -7,000.00 |
| EPS Diluted Continuous Ops | -28.56 | -2,191.78 | -5,468.68 | -5,806.38 | -7,011.42 |
| EBITDA(a) | $-1,353 | $-4,544 | $-5,118 | $-7,496 | $-6,984 |